Thermo Fisher Scientific Inc.

TMO

$508.46

-6.4% last 12 months

Ken Fisher Holding value: $1.22 Billion Polen Capital Holding value: $1.15 Billion Chris Hohn Holding value: $424 Million AKO Capital Holding value: $312 Million Ken Griffin Holding value: $121 Million Ray Dalio Holding value: $48.6 Million Mario Gabelli Holding value: $8.27 Million Tom Gayner Holding value: $4.17 Million Joel Greenblatt Holding value: $1.27 Million Steven Cohen Holding value: $0 Jeremy Grantham Holding value: $0 Julian Robertson Holding value: $0 Jim Simons Holding value: $0 Tom Russo Holding value: $0 Cathie Wood Holding value: $0 Daniel Loeb Holding value: $0 Chris Davis Holding value: $0 George Soros Holding value: $0 David Tepper Holding value: $0 Prem Watsa Holding value: $0 Seth Klarman Holding value: $0

Market Cap

$200 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$475.21 - $610.02

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

33.26x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$1.25 (0.24%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $200 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. $232 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $1.25 (0.24%)
1 Year Return Profit or loss of share price change plus dividend yield. -6.2%
52-Week High Highest share price in the last 52 weeks. $610.02
52-Week Low Lowest share price in the last 52 weeks. $475.21
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 0.98
Outstanding Shares The number of shares the company has issued and are held by stockholders. 386 Million
Avg 30 Day Volume The number of shares traded in the last 30 days. 1.63 Million

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 33.26
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. -79.55
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. $15.36
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 4.5
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 4.66
Enterprise Value to Revenue Enterprise value divided by revenue 5.3
Enterprise Value to EBIT Enterprise Value divided by EBIT 32.32
Total Debt to Enterprise Value Total debt divided by enterprise value 0.15
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.83

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. $43.8 Billion
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. $17.6 Billion
EBIT Earnings before tax and interest payments. $7.18 Billion
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. $6.02 Billion
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 13.75%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -41.8%
Return on Equity Equity divided by market cap. 14.26%
Return on Assets Indicates a company's profitability in relation to its total assets. 6.36%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 9.12%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q3 2022 Q4 2022 Q1 2023 Q2 2023

About Thermo Fisher Scientific Inc.

CEO: Marc Casper

Employees: 75,000

Industry: Testing Laboratories

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, the company is here to support them. Its global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Similar stocks

Revvity Inc.
Revvity Inc.
Becton, Dickinson And Co.
Becton, Dickinson And Co.
Waters Corp.
Waters Corp.
Bio-Rad Laboratories Inc. - Class A
Bio-Rad Laboratories Inc. - Class A
Intuitive Surgical Inc
Intuitive Surgical Inc
Teleflex Incorporated
Teleflex Incorporated
Agilent Technologies Inc.
Agilent Technologies Inc.
Baxter International Inc.
Baxter International Inc.
Danaher Corp.
Danaher Corp.
General Electric Co.
General Electric Co.

News

Gene Editing Technologies Global Market to 2032: Introduction of New Technologies Fuelling the Growth of Gene Editing Technologies

Gene Editing Technologies Global Market to 2032: Introduction of New Technologies Fuelling the Growth of Gene Editing Technologies

Kwhen Finance Kwhen Finance, about 19 hours ago
Catalyst Capital Advisors LLC Boosts Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

Catalyst Capital Advisors LLC Boosts Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

Catalyst Capital Advisors LLC raised its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Get Rating) by 27.6% in the fourth quarter, accordin...

The AM Reporter The AM Reporter, 1 day ago
Buy Thermo Fisher, But With Caution

Buy Thermo Fisher, But With Caution

Thermo Fisher Scientific experienced significant growth over the past 20 years. Read why TMO stock is a Buy, but I would recommend adding only on weakness.

Seeking Alpha Seeking Alpha, 2 days ago
Global Market for Laser Therapy Devices is expected to reach worth US$ 7 Billion, registering a CAGR of 8.8% by forecast 2033 end | Future Market Insights, Inc.

Global Market for Laser Therapy Devices is expected to reach worth US$ 7 Billion, registering a CAGR of 8.8% by forecast 2033 end | Future Market Insights, Inc.

NEWARK, DE / ACCESSWIRE / May 30, 2023 / The Laser Therapy Devices Market is predicted to be valued at US$ 3 billion in 2023 and US$ 7 billion by 2033. Over ...

Accesswire Accesswire, 4 days ago
Never miss a trade
To improve your user experience we use cookies.